Platform Session 4: Prenatal and Newborn Genetics
20 Mar 2025
Meeting Room:
502 AB
Clinical Genetics and Therapeutics
,
Health Services and Implementation
,
Prenatal Genetics
-
Accredited:
- Accredited
Platform presentations are abstract submissions chosen by the abstract review committee to orally present their research. It is a 13-minute presentation followed by a 2-minute Q&A.
O18 - BabyFORce: A Pioneering Program Translating Variants Identified via Rapid Genome Sequencing to Targeted Therapeutics for Neonatal Intensive Care Unit Patients
O22 - GUARDIAN Expanded Newborn Screening Study: Early Experiences
O48 - International Consortium on Newborn Sequencing (ICoNS) Consensus Guidelines for Gene Selection in Genomic Newborn Screening Programs
O49 - Estimate of the Cost of Informed Consent in NBS: The ScreenPlus Model
O63 - Leveraging Global and Local Genomic Data to Guide Equitable Carrier Screening: From Genome Aggregation Database (gnomAD) to Qatar Genome
O64 - Efficacy of Non-invasive Preimplantation Genetic Testing for Aneuploidies in IVF/ICSI Patients: A Prospective Real-world Study
O18 - BabyFORce: A Pioneering Program Translating Variants Identified via Rapid Genome Sequencing to Targeted Therapeutics for Neonatal Intensive Care Unit Patients
O22 - GUARDIAN Expanded Newborn Screening Study: Early Experiences
O48 - International Consortium on Newborn Sequencing (ICoNS) Consensus Guidelines for Gene Selection in Genomic Newborn Screening Programs
O49 - Estimate of the Cost of Informed Consent in NBS: The ScreenPlus Model
O63 - Leveraging Global and Local Genomic Data to Guide Equitable Carrier Screening: From Genome Aggregation Database (gnomAD) to Qatar Genome
O64 - Efficacy of Non-invasive Preimplantation Genetic Testing for Aneuploidies in IVF/ICSI Patients: A Prospective Real-world Study
Agenda
-
Welcome1:30 PM – 3:00 PM -
BabyFORce: A Pioneering Program Translating Variants Identified via Rapid Genome Sequencing to Targeted Therapeutics for Neonatal Intensive Care Unit Patients1:30 PM – 1:45 PM -
GUARDIAN Expanded Newborn Screening Study: Early Experiences1:45 PM – 2:00 PM -
International Consortium on Newborn Sequencing (ICoNS) Consensus Guidelines for Gene Selection in Genomic Newborn Screening Programs2:00 PM – 2:15 PM -
Estimate of the Cost of Informed Consent in NBS: The ScreenPlus Model2:15 PM – 2:30 PM -
Leveraging Global and Local Genomic Data to Guide Equitable Carrier Screening: From Genome Aggregation Database (gnomAD) to Qatar Genome2:30 PM – 2:45 PM -
Efficacy of Non-invasive Preimplantation Genetic Testing for Aneuploidies in IVF/ICSI Patients: A Prospective Real-world Study2:45 PM – 3:00 PM
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
)
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}